152 related articles for article (PubMed ID: 16260699)
21. Management of cutaneous melanoma.
Tsao H; Atkins MB; Sober AJ
N Engl J Med; 2004 Sep; 351(10):998-1012. PubMed ID: 15342808
[No Abstract] [Full Text] [Related]
22. Adjuvant interferon therapy and rheumatoid arthritis--a contraindication?
Tsianakas A; Schiller M; Luger TA; Sunderkoetter C
Acta Oncol; 2009; 48(3):468-9. PubMed ID: 18759142
[No Abstract] [Full Text] [Related]
23. [Recommendation of the Hungarian Society for Face, Mandible and Oral Surgery in the indication of supportive therapy with Avemar].
Barabás J; Németh Z
Orv Hetil; 2006 Sep; 147(35):1709-11. PubMed ID: 17051748
[No Abstract] [Full Text] [Related]
24. The systemic treatment of advanced cutaneous melanoma.
Logan TF
Facial Plast Surg Clin North Am; 2003 Feb; 11(1):75-85. PubMed ID: 15062290
[No Abstract] [Full Text] [Related]
25. Atrophie blanche associated with interferon-alfa adjuvant therapy for melanoma: a cutaneous side effect related to the procoagulant activity of interferon?
Bugatti L; Filosa G; Nicolini M; Filosa A; Verdolini R
Dermatology; 2002; 204(2):154. PubMed ID: 11937746
[No Abstract] [Full Text] [Related]
26. The role of adjuvant interferon in high risk melanoma patients.
Dermatol Surg; 2000 Jun; 26(6):607-8. PubMed ID: 10848951
[No Abstract] [Full Text] [Related]
27. [Sarcoidosis, myasthenia gravis and anterior ischaemic optic neuropathy: severe side effects of adjuvant interferon-alpha-therapy in malignant melanoma?].
Kreutzer K; Bonnekoh B; Franke I; Ulrich J; Gollnick H
J Dtsch Dermatol Ges; 2004 Aug; 2(8):689-94. PubMed ID: 16279234
[TBL] [Abstract][Full Text] [Related]
28. Noninterferon-based adjuvant therapy for high-risk melanoma.
Spitler LE
Expert Rev Anticancer Ther; 2002 Oct; 2(5):547-62. PubMed ID: 12382523
[TBL] [Abstract][Full Text] [Related]
29. How melanoma is treated in real life.
Dummer R; Schadendorf D
Arch Dermatol; 2008 May; 144(5):664-5. PubMed ID: 18490596
[No Abstract] [Full Text] [Related]
30. [Melanoma: a new interferon is coming ... handle with care!].
Négrier S
Bull Cancer; 1997 Apr; 84(4):435-7. PubMed ID: 9238171
[No Abstract] [Full Text] [Related]
31. Concurrent interferon-alpha and radiation for head and neck melanoma.
Nguyen NP; Levinson B; Dutta S; Karlsson U; Alfieri A; Childress C; Sallah S
Melanoma Res; 2003 Feb; 13(1):67-71. PubMed ID: 12569287
[TBL] [Abstract][Full Text] [Related]
32. Adjuvant therapy in patients with resected poor-risk head and neck cancer.
Bernier J; Vermorken JB; Koch WM
J Clin Oncol; 2006 Jun; 24(17):2629-35. PubMed ID: 16763276
[TBL] [Abstract][Full Text] [Related]
33. Chemotherapy, cytokines, and biochemotherapy for melanoma.
Eton O
Cancer Chemother Biol Response Modif; 2005; 22():739-48. PubMed ID: 16110637
[No Abstract] [Full Text] [Related]
34. Adjuvant interferon for stage II melanoma.
Haluska FG
J Clin Oncol; 1998 Sep; 16(9):3205-6. PubMed ID: 9738597
[No Abstract] [Full Text] [Related]
35. [Interferon for adjuvant therapy of melanoma: approved, not indicated].
Croockewit AJ; Koopmans PP; Lekkerkerker JF
Ned Tijdschr Geneeskd; 2001 Mar; 145(10):498-9. PubMed ID: 11268915
[No Abstract] [Full Text] [Related]
36. Cytokine therapy in advanced melanoma.
Kalaaji AN
J Drugs Dermatol; 2007 Apr; 6(4):374-8. PubMed ID: 17668534
[TBL] [Abstract][Full Text] [Related]
37. Adjuvant high-dose interferon revisited.
Sondak VK; Flaherty LE
Cancer J; 2000; 6(3):132-4. PubMed ID: 10882326
[No Abstract] [Full Text] [Related]
38. Report on the 4th International Conference on the Adjuvant Therapy of Malignant Melanoma held at the Royal College of Physicians, London, UK, 15-16 March 2002.
Retsas S; Falkson C; Spitler L
Melanoma Res; 2002 Jun; 12(3):A1-4. PubMed ID: 12140389
[No Abstract] [Full Text] [Related]
39. [Interferon-alpha can improve the prognosis in high-risk melanoma. Combination of surgery, cytostatics and natural IFN-alpha doubled the survival rate].
Strannegärd O; Thorén FB; Lundgren E
Lakartidningen; 2008 Feb 6-12; 105(6):358-61. PubMed ID: 18380352
[No Abstract] [Full Text] [Related]
40. Need for a quantitative meta-analysis of trials of adjuvant interferon in melanoma.
Wheatley K; Ives N; Hancock B; Gore M
J Clin Oncol; 2002 Oct; 20(19):4120-1; author reply 4121-2. PubMed ID: 12351611
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
